samedan logo
 
 
spacer
home > pmps > summer 2007 > pure water for clear results
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Pure Water for Clear Results

An on demand supply of purified water is essential for pharmaceutical laboratories to operate effectively, explains Mark Bosley of Purite

Purified water is used for a wide range of applications in pharmaceutical laboratories, from drug formulations to glassware rinsing. In order for these to be carried out effectively and safely, the water used needs to be suitably processed and treated to eliminate microbial, chemical and endotoxin contaminants. The latest generation of water purification technology is now making this achievable more simply and cost-effectively than was previously possible.

A range of solutions is now available to produce varying levels of water purity for different applications, with the highest levels typically being required in cell culture, media preparation, DNA sequencing and genome research. It is worth noting that water purity for these applications is normally measured in terms of either resistance (expressed as Megohms centimetre or MΩcm) or conductivity (measured in microSiemens per centimetre or μS/cm), as the concentration of ionic contaminants will determine the level of electrical conductivity.

MEASURING QUALITY

In the pharmaceutical industry, water quality is regulated by various national and international bodies, specifying three commonly used grades of water. The United States Pharmacopoeia (USP) specify two grades – purified water (PW) and water for injection (WFI), whereas the European Pharmacopoeia (EP) specify an additional grade – highly purified water (HPW).

These pharmacopoeia outline specific parameters and measuring criteria for the water used for certain applications; however, they do not typically detail the system design considerations or maintenance regimes necessary to achieve these quality levels. This falls within the remit of a number of validating bodies, such as the US Food and Drug Administration (FDA), which aim to ensure compliance with standards by checking that system design, installation, monitoring and maintenance procedures are in place to facilitate consistent and traceable performance to the relevant standards. In addition to these organisations, a number of documents are available, such as the current good manufacturing practice (cGMP) and the ISPE Water and Steam Guide, which also provides assistance for organisations with purified water requirements.


Read full article >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
5
     

There are no comments in regards to this article.

spacer
Mark Bosley has worked for Purite for over 11 years and is currently employed as a Technical Specialist, working within the company’s team of development experts for advanced custom-built and standard plant for the pharmaceutical and related sectors. In total, Mark has over 25 years’ experience in the water treatment industry. This has included work in the development of water purification systems for boiler feed, cooling towers, heating and ventilating equipment and, more recently, in the design of specialised purified water systems for a variety of market sectors, including brewing and distilling, food processing and healthcare. Mark is also a leading contributor and speaker at medical and healthcare conferences, with particular expertise in the design and specification of large ultrafiltration systems, and in writing detailed validation documentation for all types of water purification plant.
spacer
Mark Bosley
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

EMBALLAGE 2008. World Packaging Exhibition

16-21 November 2008, Paris-Nord Villepinte - France

“Business, Innovation, Outlook” are the watchwords for the 38th World Packaging Exhibition which opens in Paris from 17 to 21 November 2008. Fifteen months before the key packaging event of the end of 2008, EMBALLAGE displays its differences to offer you a new edition that is even more representative, international and rich in new features.
More info >>

 
News and Press Releases

Azopharma Announces Plans to Implement XcelodoseTM Technology in the Production of Early Stage Clinical Trial Materials

HOLLYWOOD, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) announced today plans to implement Xcelodose technology at its formulations development facility, ApiCross Drug Delivery Technologies. Xcelodose technology is a powder micro-dosing system developed by Meridica. This technology offers a unique powder dispensing system for small-scale capsule filling and ultimately assists in conserving valuable research material as well as reducing various Preformulation activities.
More info >>

 

©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page

Send to a friend
Privacy statement